Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Theophylline/ephedra/hydroxyzine

From Wikipedia, the free encyclopedia
(Redirected from Marax)
Theophylline/ephedra/hydroxyzine
Combination of
TheophyllineStimulant
Ephedra (medicine)Stimulant
HydroxyzineAntihistamine
Clinical data
Trade namesMarax
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
administration
By mouth
ATC code
Identifiers
CAS Number
PubChem SID

Theophylline/ephedra/hydroxyzine (trade name Marax) is a drug that was used for the treatment of asthma. It was a combination of theophylline, ephedra,[1] and hydroxyzine, and taken by mouth.[2][3] It is no longer manufactured in the US due to approval of ephedra being withdrawn by the FDA.[citation needed]

See also

[edit]

References

[edit]
  1. Hunt TM (2011). Drug Games: The International Olympic Committee and the Politics of Doping, 1960–2008. University of Texas Press. p. 45. ISBN 978-0-292-73957-4. Retrieved 20 July 2018.
  2. Marax Micromedex Detailed Consumer Information. Accessed 23 April 2021.
  3. Fixley M, Shen DD, Azarnoff DL (June 1977). "Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline". The American Review of Respiratory Disease. 115 (6): 955–62. doi:10.1164/arrd.1977.115.6.955 (inactive 12 July 2025). PMID 262107.{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link)